$CRBU
Caribou Biosciences, Inc.
Runway:1 mo
NasdaqMarket cap: —CIK 0001619856
Upcoming catalysts
0 surfacedNo catalysts surfaced for CRBU yet.
Drug pipeline
Recent & active trials
| NCT | Drug | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT05332054 | Caribou-sponsored investigational therapy | — | Enrolling By Invitation | 2041-12-01 |
| NCT06752876 | CB-010 | Phase 1 | Withdrawn | 2029-04-01 |
| NCT05722418 | CB-011 | Phase 1 | Recruiting | 2027-12-01 |
| NCT04637763 | Cyclophosphamide | Phase 1 | Unknown | 2025-08-01 |
| NCT06128044 | CB-012 | Phase 1 | Terminated | 2025-05-30 |